Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
Under an Elsevier user license
open archive
Cited by (0)
- *
From the Maryland Medical Research Institute, Baltimore, Maryland
- †
From the Mayo Clinic, Rochester, Minnesota
- ‡
From the Emory University School of Medicine, Atlanta, Georgia
- §
From the Northwestern University Medical School, Chicago, Illinois
- ‖
From the National Heart, Lung, and Blood Institute, Bethesda, Maryland
- **
From the School of Public Health, University of Minnesota, Minneapolis, Minnesota. The Coronary Drug Project was carried out as a collaborative study supported by research grants and other funds from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.
- ††
A list of the key bodies and senior staff members of the Coronary Drug Project Mortality Follow-Up Program is presented in Appendix B.
Copyright © 1986 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.